Tumor necrosis factor-alpha gene −308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers

OBJECTIVESAs is well known, acute myocardial infarction presents two electrocardiogram (EKG) patterns, ST-elevation (STEMI) and no ST-elevation (NSTEMI), characterized by different coronary artery thrombotic occlusion. Growing evidence shows that inflammation plays a central role in the pathogenesis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Coronary artery disease 2005-12, Vol.16 (8), p.489-493
Hauptverfasser: Antonicelli, Roberto, Olivieri, Fabiola, Cavallone, Luca, Spazzafumo, Liana, Bonafè, Massimiliano, Marchegiani, Francesca, Cardelli, Maurizio, Galeazzi, Roberta, Giovagnetti, Simona, Perna, Gian Piero, Franceschi, Claudio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 493
container_issue 8
container_start_page 489
container_title Coronary artery disease
container_volume 16
creator Antonicelli, Roberto
Olivieri, Fabiola
Cavallone, Luca
Spazzafumo, Liana
Bonafè, Massimiliano
Marchegiani, Francesca
Cardelli, Maurizio
Galeazzi, Roberta
Giovagnetti, Simona
Perna, Gian Piero
Franceschi, Claudio
description OBJECTIVESAs is well known, acute myocardial infarction presents two electrocardiogram (EKG) patterns, ST-elevation (STEMI) and no ST-elevation (NSTEMI), characterized by different coronary artery thrombotic occlusion. Growing evidence shows that inflammation plays a central role in the pathogenesis of acute myocardial infarction. Among the factors that promote inflammation and arterial thrombosis, one of the most important is the proinflammatory cytokine tumor necrosis factor-α. The expression of this cytokine is modulated by a polymorphism located at nucleotide −308 of tumor necrosis factor-α promoter gene. The objective of our study is to verify whether tumor necrosis factor-α −308 polymorphism is associated with risk of acute myocardial infarction (STEMI and NSTEMI) or with biochemical myocardial ischemia markers, such as troponin I, creatine kinase-MB, lactate dehydrogenase and myoglobin. METHODSWe analyzed tumor necrosis factor-α −308 polymorphism in a total of 603 study participants293 elderly patients affected by acute myocardial infarction (STEMI and NSTEMI) and 310 healthy controls. RESULTSWe found that individuals carrying the tumor necrosis factor-α −308 AG+AA genotypes are significantly more represented among acute myocardial infarction patients affected by STEMI than among NSTEMI patients (OR=1.86, 95% CI 1.08–3.21, p=0.027) and healthy controls (OR=1.64, 95% CI 1.03–2.64, p=0.046). Furthermore, the patients carrying tumor necrosis factor-α −308 AG+AA genotypes displayed significant increased levels of biochemical myocardial ischemia markers. CONCLUSIONSOur study shows a significant association between the tumor necrosis factor-α −308 polymorphism and the occurrence of STEMI, and suggests that the tumor necrosis factor-α −308 polymorphism could play a role in the pathogenesis of cardiac ischemic damage, AA+AG genotype carrier individuals being likely to be affected by more severe ischemic damage than the rest of the population.
doi_str_mv 10.1097/00019501-200512000-00006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68851777</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68851777</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3586-9752f0cb07d2f18cc1a00bf1ac51d54b29dcc600c415bbf514dffba31a3077ba3</originalsourceid><addsrcrecordid>eNp1kc-O1SAUh4nRONfRVzCs3KGHtpR2YzKZOKPJJC68rskphSkOLRVab-4buPYtfC2fRO4fdeUCOCHfDw58hFAOrzm08g0A8FYAZwWA4HkClgfUj8iGV7JkoinhMdlAKypWt0VzQZ6l9CWHKiHFU3LB65K3tWg35Od2HUOkk9ExJJeoRb2EyNDPA9J7Mxn66_uPEprbt1d0Dn6f4XlwaaSZxZSCdriYnu7cMtBPW2a8-YaLCxMd90Fj7B166iaLUR93cTqzg7sf6OwxjUhzxvhEg6WdC3owo9OHVDqWSEeMDyam5-SJRZ_Mi_N6ST7fvNtev2d3H28_XF_dMV2KpmatFIUF3YHsC8sbrTkCdJajFrwXVVe0vdY1gK646DoreNVb22HJsQQpc3FJXp3OnWP4upq0qDG3YrzHyYQ1qbppBJdSZrA5gYevS9FYNUeXm90rDuqgSf3RpP5qUkdNOfryfMfajab_Fzx7yUB1AnbBL_nxD37dmagGg34Z1P_0l78B3zWh4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68851777</pqid></control><display><type>article</type><title>Tumor necrosis factor-alpha gene −308G&gt;A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Antonicelli, Roberto ; Olivieri, Fabiola ; Cavallone, Luca ; Spazzafumo, Liana ; Bonafè, Massimiliano ; Marchegiani, Francesca ; Cardelli, Maurizio ; Galeazzi, Roberta ; Giovagnetti, Simona ; Perna, Gian Piero ; Franceschi, Claudio</creator><creatorcontrib>Antonicelli, Roberto ; Olivieri, Fabiola ; Cavallone, Luca ; Spazzafumo, Liana ; Bonafè, Massimiliano ; Marchegiani, Francesca ; Cardelli, Maurizio ; Galeazzi, Roberta ; Giovagnetti, Simona ; Perna, Gian Piero ; Franceschi, Claudio</creatorcontrib><description>OBJECTIVESAs is well known, acute myocardial infarction presents two electrocardiogram (EKG) patterns, ST-elevation (STEMI) and no ST-elevation (NSTEMI), characterized by different coronary artery thrombotic occlusion. Growing evidence shows that inflammation plays a central role in the pathogenesis of acute myocardial infarction. Among the factors that promote inflammation and arterial thrombosis, one of the most important is the proinflammatory cytokine tumor necrosis factor-α. The expression of this cytokine is modulated by a polymorphism located at nucleotide −308 of tumor necrosis factor-α promoter gene. The objective of our study is to verify whether tumor necrosis factor-α −308 polymorphism is associated with risk of acute myocardial infarction (STEMI and NSTEMI) or with biochemical myocardial ischemia markers, such as troponin I, creatine kinase-MB, lactate dehydrogenase and myoglobin. METHODSWe analyzed tumor necrosis factor-α −308 polymorphism in a total of 603 study participants293 elderly patients affected by acute myocardial infarction (STEMI and NSTEMI) and 310 healthy controls. RESULTSWe found that individuals carrying the tumor necrosis factor-α −308 AG+AA genotypes are significantly more represented among acute myocardial infarction patients affected by STEMI than among NSTEMI patients (OR=1.86, 95% CI 1.08–3.21, p=0.027) and healthy controls (OR=1.64, 95% CI 1.03–2.64, p=0.046). Furthermore, the patients carrying tumor necrosis factor-α −308 AG+AA genotypes displayed significant increased levels of biochemical myocardial ischemia markers. CONCLUSIONSOur study shows a significant association between the tumor necrosis factor-α −308 polymorphism and the occurrence of STEMI, and suggests that the tumor necrosis factor-α −308 polymorphism could play a role in the pathogenesis of cardiac ischemic damage, AA+AG genotype carrier individuals being likely to be affected by more severe ischemic damage than the rest of the population.</description><identifier>ISSN: 0954-6928</identifier><identifier>EISSN: 1473-5830</identifier><identifier>DOI: 10.1097/00019501-200512000-00006</identifier><identifier>PMID: 16319659</identifier><language>eng</language><publisher>England: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Aged ; Aged, 80 and over ; Biomarkers - blood ; Creatine Kinase, MB Form - blood ; Electrocardiography ; Female ; Humans ; L-Lactate Dehydrogenase - blood ; Male ; Myocardial Infarction - genetics ; Myocardial Infarction - physiopathology ; Myocardial Ischemia - genetics ; Myocardial Ischemia - physiopathology ; Myoglobin - blood ; Polymorphism, Genetic ; Risk Factors ; Troponin I - blood ; Tumor Necrosis Factor-alpha - genetics</subject><ispartof>Coronary artery disease, 2005-12, Vol.16 (8), p.489-493</ispartof><rights>2005 Lippincott Williams &amp; Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3586-9752f0cb07d2f18cc1a00bf1ac51d54b29dcc600c415bbf514dffba31a3077ba3</citedby><cites>FETCH-LOGICAL-c3586-9752f0cb07d2f18cc1a00bf1ac51d54b29dcc600c415bbf514dffba31a3077ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16319659$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Antonicelli, Roberto</creatorcontrib><creatorcontrib>Olivieri, Fabiola</creatorcontrib><creatorcontrib>Cavallone, Luca</creatorcontrib><creatorcontrib>Spazzafumo, Liana</creatorcontrib><creatorcontrib>Bonafè, Massimiliano</creatorcontrib><creatorcontrib>Marchegiani, Francesca</creatorcontrib><creatorcontrib>Cardelli, Maurizio</creatorcontrib><creatorcontrib>Galeazzi, Roberta</creatorcontrib><creatorcontrib>Giovagnetti, Simona</creatorcontrib><creatorcontrib>Perna, Gian Piero</creatorcontrib><creatorcontrib>Franceschi, Claudio</creatorcontrib><title>Tumor necrosis factor-alpha gene −308G&gt;A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers</title><title>Coronary artery disease</title><addtitle>Coron Artery Dis</addtitle><description>OBJECTIVESAs is well known, acute myocardial infarction presents two electrocardiogram (EKG) patterns, ST-elevation (STEMI) and no ST-elevation (NSTEMI), characterized by different coronary artery thrombotic occlusion. Growing evidence shows that inflammation plays a central role in the pathogenesis of acute myocardial infarction. Among the factors that promote inflammation and arterial thrombosis, one of the most important is the proinflammatory cytokine tumor necrosis factor-α. The expression of this cytokine is modulated by a polymorphism located at nucleotide −308 of tumor necrosis factor-α promoter gene. The objective of our study is to verify whether tumor necrosis factor-α −308 polymorphism is associated with risk of acute myocardial infarction (STEMI and NSTEMI) or with biochemical myocardial ischemia markers, such as troponin I, creatine kinase-MB, lactate dehydrogenase and myoglobin. METHODSWe analyzed tumor necrosis factor-α −308 polymorphism in a total of 603 study participants293 elderly patients affected by acute myocardial infarction (STEMI and NSTEMI) and 310 healthy controls. RESULTSWe found that individuals carrying the tumor necrosis factor-α −308 AG+AA genotypes are significantly more represented among acute myocardial infarction patients affected by STEMI than among NSTEMI patients (OR=1.86, 95% CI 1.08–3.21, p=0.027) and healthy controls (OR=1.64, 95% CI 1.03–2.64, p=0.046). Furthermore, the patients carrying tumor necrosis factor-α −308 AG+AA genotypes displayed significant increased levels of biochemical myocardial ischemia markers. CONCLUSIONSOur study shows a significant association between the tumor necrosis factor-α −308 polymorphism and the occurrence of STEMI, and suggests that the tumor necrosis factor-α −308 polymorphism could play a role in the pathogenesis of cardiac ischemic damage, AA+AG genotype carrier individuals being likely to be affected by more severe ischemic damage than the rest of the population.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers - blood</subject><subject>Creatine Kinase, MB Form - blood</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Humans</subject><subject>L-Lactate Dehydrogenase - blood</subject><subject>Male</subject><subject>Myocardial Infarction - genetics</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Myocardial Ischemia - genetics</subject><subject>Myocardial Ischemia - physiopathology</subject><subject>Myoglobin - blood</subject><subject>Polymorphism, Genetic</subject><subject>Risk Factors</subject><subject>Troponin I - blood</subject><subject>Tumor Necrosis Factor-alpha - genetics</subject><issn>0954-6928</issn><issn>1473-5830</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc-O1SAUh4nRONfRVzCs3KGHtpR2YzKZOKPJJC68rskphSkOLRVab-4buPYtfC2fRO4fdeUCOCHfDw58hFAOrzm08g0A8FYAZwWA4HkClgfUj8iGV7JkoinhMdlAKypWt0VzQZ6l9CWHKiHFU3LB65K3tWg35Od2HUOkk9ExJJeoRb2EyNDPA9J7Mxn66_uPEprbt1d0Dn6f4XlwaaSZxZSCdriYnu7cMtBPW2a8-YaLCxMd90Fj7B166iaLUR93cTqzg7sf6OwxjUhzxvhEg6WdC3owo9OHVDqWSEeMDyam5-SJRZ_Mi_N6ST7fvNtev2d3H28_XF_dMV2KpmatFIUF3YHsC8sbrTkCdJajFrwXVVe0vdY1gK646DoreNVb22HJsQQpc3FJXp3OnWP4upq0qDG3YrzHyYQ1qbppBJdSZrA5gYevS9FYNUeXm90rDuqgSf3RpP5qUkdNOfryfMfajab_Fzx7yUB1AnbBL_nxD37dmagGg34Z1P_0l78B3zWh4A</recordid><startdate>200512</startdate><enddate>200512</enddate><creator>Antonicelli, Roberto</creator><creator>Olivieri, Fabiola</creator><creator>Cavallone, Luca</creator><creator>Spazzafumo, Liana</creator><creator>Bonafè, Massimiliano</creator><creator>Marchegiani, Francesca</creator><creator>Cardelli, Maurizio</creator><creator>Galeazzi, Roberta</creator><creator>Giovagnetti, Simona</creator><creator>Perna, Gian Piero</creator><creator>Franceschi, Claudio</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200512</creationdate><title>Tumor necrosis factor-alpha gene −308G&gt;A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers</title><author>Antonicelli, Roberto ; Olivieri, Fabiola ; Cavallone, Luca ; Spazzafumo, Liana ; Bonafè, Massimiliano ; Marchegiani, Francesca ; Cardelli, Maurizio ; Galeazzi, Roberta ; Giovagnetti, Simona ; Perna, Gian Piero ; Franceschi, Claudio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3586-9752f0cb07d2f18cc1a00bf1ac51d54b29dcc600c415bbf514dffba31a3077ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers - blood</topic><topic>Creatine Kinase, MB Form - blood</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Humans</topic><topic>L-Lactate Dehydrogenase - blood</topic><topic>Male</topic><topic>Myocardial Infarction - genetics</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Myocardial Ischemia - genetics</topic><topic>Myocardial Ischemia - physiopathology</topic><topic>Myoglobin - blood</topic><topic>Polymorphism, Genetic</topic><topic>Risk Factors</topic><topic>Troponin I - blood</topic><topic>Tumor Necrosis Factor-alpha - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Antonicelli, Roberto</creatorcontrib><creatorcontrib>Olivieri, Fabiola</creatorcontrib><creatorcontrib>Cavallone, Luca</creatorcontrib><creatorcontrib>Spazzafumo, Liana</creatorcontrib><creatorcontrib>Bonafè, Massimiliano</creatorcontrib><creatorcontrib>Marchegiani, Francesca</creatorcontrib><creatorcontrib>Cardelli, Maurizio</creatorcontrib><creatorcontrib>Galeazzi, Roberta</creatorcontrib><creatorcontrib>Giovagnetti, Simona</creatorcontrib><creatorcontrib>Perna, Gian Piero</creatorcontrib><creatorcontrib>Franceschi, Claudio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Coronary artery disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Antonicelli, Roberto</au><au>Olivieri, Fabiola</au><au>Cavallone, Luca</au><au>Spazzafumo, Liana</au><au>Bonafè, Massimiliano</au><au>Marchegiani, Francesca</au><au>Cardelli, Maurizio</au><au>Galeazzi, Roberta</au><au>Giovagnetti, Simona</au><au>Perna, Gian Piero</au><au>Franceschi, Claudio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumor necrosis factor-alpha gene −308G&gt;A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers</atitle><jtitle>Coronary artery disease</jtitle><addtitle>Coron Artery Dis</addtitle><date>2005-12</date><risdate>2005</risdate><volume>16</volume><issue>8</issue><spage>489</spage><epage>493</epage><pages>489-493</pages><issn>0954-6928</issn><eissn>1473-5830</eissn><abstract>OBJECTIVESAs is well known, acute myocardial infarction presents two electrocardiogram (EKG) patterns, ST-elevation (STEMI) and no ST-elevation (NSTEMI), characterized by different coronary artery thrombotic occlusion. Growing evidence shows that inflammation plays a central role in the pathogenesis of acute myocardial infarction. Among the factors that promote inflammation and arterial thrombosis, one of the most important is the proinflammatory cytokine tumor necrosis factor-α. The expression of this cytokine is modulated by a polymorphism located at nucleotide −308 of tumor necrosis factor-α promoter gene. The objective of our study is to verify whether tumor necrosis factor-α −308 polymorphism is associated with risk of acute myocardial infarction (STEMI and NSTEMI) or with biochemical myocardial ischemia markers, such as troponin I, creatine kinase-MB, lactate dehydrogenase and myoglobin. METHODSWe analyzed tumor necrosis factor-α −308 polymorphism in a total of 603 study participants293 elderly patients affected by acute myocardial infarction (STEMI and NSTEMI) and 310 healthy controls. RESULTSWe found that individuals carrying the tumor necrosis factor-α −308 AG+AA genotypes are significantly more represented among acute myocardial infarction patients affected by STEMI than among NSTEMI patients (OR=1.86, 95% CI 1.08–3.21, p=0.027) and healthy controls (OR=1.64, 95% CI 1.03–2.64, p=0.046). Furthermore, the patients carrying tumor necrosis factor-α −308 AG+AA genotypes displayed significant increased levels of biochemical myocardial ischemia markers. CONCLUSIONSOur study shows a significant association between the tumor necrosis factor-α −308 polymorphism and the occurrence of STEMI, and suggests that the tumor necrosis factor-α −308 polymorphism could play a role in the pathogenesis of cardiac ischemic damage, AA+AG genotype carrier individuals being likely to be affected by more severe ischemic damage than the rest of the population.</abstract><cop>England</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>16319659</pmid><doi>10.1097/00019501-200512000-00006</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0954-6928
ispartof Coronary artery disease, 2005-12, Vol.16 (8), p.489-493
issn 0954-6928
1473-5830
language eng
recordid cdi_proquest_miscellaneous_68851777
source MEDLINE; Journals@Ovid Complete
subjects Aged
Aged, 80 and over
Biomarkers - blood
Creatine Kinase, MB Form - blood
Electrocardiography
Female
Humans
L-Lactate Dehydrogenase - blood
Male
Myocardial Infarction - genetics
Myocardial Infarction - physiopathology
Myocardial Ischemia - genetics
Myocardial Ischemia - physiopathology
Myoglobin - blood
Polymorphism, Genetic
Risk Factors
Troponin I - blood
Tumor Necrosis Factor-alpha - genetics
title Tumor necrosis factor-alpha gene −308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T08%3A10%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumor%20necrosis%20factor-alpha%20gene%20%E2%88%92308G%3EA%20polymorphism%20is%20associated%20with%20ST-elevation%20myocardial%20infarction%20and%20with%20high%20plasma%20levels%20of%20biochemical%20ischemia%20markers&rft.jtitle=Coronary%20artery%20disease&rft.au=Antonicelli,%20Roberto&rft.date=2005-12&rft.volume=16&rft.issue=8&rft.spage=489&rft.epage=493&rft.pages=489-493&rft.issn=0954-6928&rft.eissn=1473-5830&rft_id=info:doi/10.1097/00019501-200512000-00006&rft_dat=%3Cproquest_cross%3E68851777%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68851777&rft_id=info:pmid/16319659&rfr_iscdi=true